Funded in part by Novo Nordisk, Novo Nordisk Fonden, Novo Nordisk Foundation
Nut Consumption Is Associated with Lower Risk of Metabolic Syndrome and Its Components in Type 1 Diabetes
Ahola AJ, Forsblom CM, Harjutsalo V, Groop PH
Nutrients · 14 citations
Review labels
Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.
How it was studied
- Design
- Cross-sectional study (classified by our AI screen)
- Studied in
- People
- Main outcome
- Health markers and function
- Intake measured by
- Food diaries or recalls
Who paid for it
- Funding
- Industry funded
- Nonprofit
- Wilhelm och Else Stockmanns Stiftelse
- Nonprofit
- Folkhälsanin Tutkimussäätiö
- Government
- Academy of Finland
- Company
- Novo Nordisk
- Nonprofit
- Päivikki ja Sakari Sohlbergin Säätiö
- Nonprofit
- Signe ja Ane Gyllenbergin Säätiö
- Nonprofit
- Samfundet Folkhälsan
- Company
- Novo Nordisk Fonden
- Nonprofit
- Folkhälsan Research Foundation
- Nonprofit
- Liv och Hälsa Society
- Nonprofit
- Wilhelm and Else Stockmann Foundation
- Nonprofit
- Signe and Ane Gyllenberg Foundation
- Company
- Novo Nordisk Foundation
- Nonprofit
- Päivikki and Sakari Sohlberg Foundation
- University or hospital
- Helsinki University Hospital Research Funds
- Authors
- At least one author declares a financial tie to industry
- Grants
- Päivikki ja Sakari Sohlbergin Säätiö (TYH2018207); Folkhälsanin Tutkimussäätiö (OC0013659); Novo Nordisk Fonden (NNF14OC0013659); Novo Nordisk Fonden (316664); Novo Nordisk Fonden (#NNFOC0013659); Päivikki ja Sakari Sohlbergin Säätiö (OC0013659); Signe ja Ane Gyllenbergin Säätiö (316664); Wilhelm och Else Stockmanns Stiftelse (OC0013659); Folkhälsanin Tutkimussäätiö (316664); Novo Nordisk Fonden (OC0013659); Academy of Finland (316664); Wilhelm och Else Stockmanns Stiftelse (316664); Folkhälsanin Tutkimussäätiö (TYH2018207); Päivikki ja Sakari Sohlbergin Säätiö (316664); Signe ja Ane Gyllenbergin Säätiö (TYH2018207); Novo Nordisk Fonden (TYH2018207); Wilhelm och Else Stockmanns Stiftelse (TYH2018207); Signe ja Ane Gyllenbergin Säätiö (OC0013659)
Based on 15 listed funder(s) and full-text disclosure statement.
Publication
- Published
- 2021-10-30 · Nutrients · vol. 13 · issue 11 · p. 3909
- Publisher
- Multidisciplinary Digital Publishing Institute
- Cited
- 15 citations · more than 71% of similar papers · 0.9× the field average
- References
- 40 works
- Access
- Open access (journal) · CC-BY
- Research areas
- Nuts composition and effects · Antioxidant Activity and Oxidative Stress · Tea Polyphenols and Effects
- Keywords
- Medicine, Metabolic syndrome, Overweight, Type 2 diabetes, Waist, Nut, Obesity, Diabetes mellitus, Triglyceride, Internal medicine, Body mass index, Cholesterol, Endocrinology, Blood pressure
- MeSH
- humans, nuts, diabetes mellitus, type 1, obesity, diet, risk factors, blood pressure, adult, middle aged, diet records, female, male, overweight, cholesterol, hdl, waist circumference, metabolic syndrome, glycemic control
4 authors
From FI, AU
- Aila J. AholaUniversity of Helsinki; Helsinki University Hospital; Folkhälsans Forskningscentrum
- Carol M. ForsblomUniversity of Helsinki; Helsinki University Hospital; Folkhälsans Forskningscentrum
- Valma HarjutsaloUniversity of Helsinki; Helsinki University Hospital; Finnish Institute for Health and Welfare; Folkhälsans Forskningscentrum
- Per‐Henrik GroopUniversity of Helsinki; Helsinki University Hospital; Folkhälsans Forskningscentrum; Monash University
Abstract
Although nut consumption has been associated with several health benefits, it has not been investigated in individuals with type 1 diabetes. Therefore, our aim was to assess nut consumption and its association with metabolic syndrome in adult individuals with type 1 diabetes taking part in the Finnish Diabetic Nephropathy Study. The nut intake of the 1058 participants was assessed from 3-day food records that were completed twice, and the number of weekly servings, assuming a serving size of 28.4 g, was calculated. Metabolic syndrome was defined as the presence of ≥3 of the cardiovascular risk factors: central obesity, high blood pressure (≥130/85 mmHg or use of antihypertensive medication), high triglyceride concentration (≥1.70 mmol/L or use of lipid-lowering medication), low HDL-cholesterol concentration (2. HbA1c > 59 mmol/mol (>7.5%) was used as a criterion for suboptimal glycaemic control. Of the 1058 (mean age 46 years, 41.6% men) participants, 689 (54.1%) reported no nut intake. In the remaining sample, the median weekly nut intake was 40.8 g. In the adjusted models, higher nut intake, as the continuous number of weekly servings and the comparison of those with 1c, and BMI. Nut consumption as a continuous variable was negatively associated with the presence of metabolic syndrome, its blood pressure, triglyceride, and HDL-cholesterol components, and suboptimal glycaemic control. Consumption of ≥2 weekly servings was associated with lower odds of suboptimal glycaemic control (by 51.5%), overweight/obesity (by 33.4%), and metabolic syndrome (by 51.8%) and meeting the waist (by 37.3%), blood pressure (by 44.5%), triglyceride (by 37.7%), and HDL-cholesterol (by 36.2%) components of the metabolic syndrome. In conclusion, a weekly nut intake of ≥2 servings was beneficially associated with all the components of the metabolic syndrome in type 1 diabetes. The causality of this association will need to be investigated.
Abstract via Europe PMC. Copyright remains with the authors or publisher (CC BY).
Community trust
Loading…
How much do you trust this study's findings?
Comments
Sign in to rate, comment on or flag this study.Sign inSomething wrong here?
Flag this study if its information, labels or funding look wrong. An editor reviews every flag.
Sign in to rate, comment on or flag this study.Sign inEducational information about published research. Not medical advice, and not a recommendation to start or stop anything.